Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma
- PMID: 23553731
- DOI: 10.1002/pd.4119
Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma
Abstract
Objective: To determine the effects of gestational age and maternal weight on percent fetal cell-free DNA (cfDNA) in maternal plasma and the change in fetal cfDNA amounts within the same patient over time.
Methods: The cfDNA was extracted from maternal plasma from 22 384 singleton pregnancies of at least 10 weeks gestation undergoing the Harmony(TM) Prenatal Test. The Harmony Prenatal Test determined fetal percentage via directed analysis of cfDNA.
Results: At 10 weeks 0 days to 10 weeks 6 days gestation, the median percent fetal cfDNA was 10.2%. Between 10 and 21 weeks gestation, percent fetal increased 0.1% per week (p < 0.0001), and 2% of pregnancies were below 4% fetal cfDNA. Beyond 21 weeks gestation, fetal cfDNA increased 1% per week (p < 0.0001). Fetal cfDNA percentage was proportional to gestational age and inversely proportional to maternal weight (p = 0.0016). Of 135 samples that were redrawn because of insufficient fetal cfDNA of the initial sample, 76 (56%) had greater than 4% fetal cfDNA in the sample from the second draw.
Conclusion: Fetal cfDNA increases with gestation, decreases with increasing maternal weight, and generally improves upon a blood redraw when the first attempt has insufficient fetal cfDNA.
© 2013 John Wiley & Sons, Ltd.
Similar articles
-
Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: effect of maternal and fetal factors.Fetal Diagn Ther. 2012;31(4):237-43. doi: 10.1159/000337373. Epub 2012 May 4. Fetal Diagn Ther. 2012. PMID: 22572044
-
Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes.Fetal Diagn Ther. 2013;33(4):215-23. doi: 10.1159/000346806. Epub 2013 Mar 5. Fetal Diagn Ther. 2013. PMID: 23466432
-
The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.Prenat Diagn. 2013 Jul;33(7):667-74. doi: 10.1002/pd.4126. Epub 2013 May 31. Prenat Diagn. 2013. PMID: 23592541
-
Prenatal assessment of fetal chromosomal and genetic disorders through maternal plasma DNA analysis.Pathology. 2012 Feb;44(2):69-72. doi: 10.1097/PAT.0b013e32834e8e29. Pathology. 2012. PMID: 22198255 Review.
-
The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis.Hum Reprod Update. 2009 Jan-Feb;15(1):139-51. doi: 10.1093/humupd/dmn047. Epub 2008 Oct 22. Hum Reprod Update. 2009. PMID: 18945714 Review.
Cited by
-
Clinical Service Delivery of Noninvasive Prenatal Diagnosis by Relative Haplotype Dosage for Single-Gene Disorders.J Mol Diagn. 2020 Sep;22(9):1151-1161. doi: 10.1016/j.jmoldx.2020.06.001. Epub 2020 Jun 15. J Mol Diagn. 2020. PMID: 32553884 Free PMC article.
-
Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issues.PLoS One. 2014 Jul 2;9(7):e101500. doi: 10.1371/journal.pone.0101500. eCollection 2014. PLoS One. 2014. PMID: 24987984 Free PMC article.
-
Non-Invasive Prenatal Testing: Current Perspectives and Future Challenges.Genes (Basel). 2020 Dec 24;12(1):15. doi: 10.3390/genes12010015. Genes (Basel). 2020. PMID: 33374411 Free PMC article. Review.
-
Isolation of HLA-G+ cells using MEM-G/9 antibody-conjugated magnetic nanoparticles for prenatal screening: a reliable, fast and efficient method.RSC Adv. 2021 Sep 20;11(49):30990-31001. doi: 10.1039/d1ra05988b. eCollection 2021 Sep 14. RSC Adv. 2021. PMID: 35498932 Free PMC article.
-
Fetal fraction evaluation in non-invasive prenatal screening (NIPS).Eur J Hum Genet. 2019 Feb;27(2):198-202. doi: 10.1038/s41431-018-0271-7. Epub 2018 Sep 25. Eur J Hum Genet. 2019. PMID: 30254213 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical